doi: 10.1289/ehp.7616127.
Role of metabolic activation in the pathogenesis of chemically induced pulmonary disease: mechanism of action of the lung-toxic furan, 4-ipomeanol
- PMID: 1017416
- PMCID: PMC1475220
- DOI: 10.1289/ehp.7616127
Item in Clipboard
Role of metabolic activation in the pathogenesis of chemically induced pulmonary disease: mechanism of action of the lung-toxic furan, 4-ipomeanol
Environ Health Perspect.
1976 Aug.
Abstract
Many xenobiotics produce hepatic injury due to their metabolism in the liver to highly reactive electrophile intermediates which form covalent conjugates with nucleophilic cellular constituents. This presentation describes studies indicating that the production of chemically reactive metabolites by pulmonary metabolism of xenobiotics can also play a fundamental role in the pathogenesis of chemically induced lung disease.
Similar articles
-
In vivo studies on the relationship between target organ alkylation and the pulmonary toxicity of a chemically reactive metabolite of 4-ipomeanol.J Pharmacol Exp Ther. 1978 Dec;207(3):687-97. J Pharmacol Exp Ther. 1978. PMID: 731424
-
Species and strain differences in target organ alkylation and toxicity by 4-ipomeanol. Predictive value of covalent binding in studies of target organ toxicities by reactive metabolites.Biochem Pharmacol. 1979 Dec 1;28(23):3367-72. doi: 10.1016/0006-2952(79)90074-1. Biochem Pharmacol. 1979. PMID: 119540 No abstract available.
-
Effects of anti-NADPH-cytochrome c reductase and anti-cytochrome b5 antibodies on the hepatic and pulmonary microsomal metabolism and covalent binding of the pulmonary toxin 4-ipomeanol.Biochem Biophys Res Commun. 1978 Sep 29;84(2):389-95. doi: 10.1016/0006-291x(78)90182-1. Biochem Biophys Res Commun. 1978. PMID: 102322 No abstract available.
-
Pulmonary metabolism of foreign compounds: its role in metabolic activation.Environ Health Perspect. 1990 Apr;85:31-41. doi: 10.1289/ehp.85-1568313. Environ Health Perspect. 1990. PMID: 2200668 Free PMC article. Review.
-
Metabolic basis for the pulmonary Clara cell as a target for pulmonary carcinogenesis.Toxicol Pathol. 1984;12(1):56-61. doi: 10.1177/019262338401200109. Toxicol Pathol. 1984. PMID: 6387866 Review.
Cited by
-
Phase II study of 4-ipomeanol, a naturally occurring alkylating furan, in patients with advanced hepatocellular carcinoma.Invest New Drugs. 2001;19(1):69-76. doi: 10.1023/a:1006408803734. Invest New Drugs. 2001. PMID: 11291834 Clinical Trial.
-
Ligand characterization of CYP4B1 isoforms modified for high-level expression in Escherichia coli and HepG2 cells.Protein Eng Des Sel. 2017 Mar 1;30(3):205-216. doi: 10.1093/protein/gzw075. Protein Eng Des Sel. 2017. PMID: 28073960 Free PMC article.
-
Acute effects of 4-ipomeanol on experimental lung tumors with bronchiolar or alveolar cell features in Syrian hamsters or C3H/HeNCr mice.J Cancer Res Clin Oncol. 1993;120(1-2):41-50. doi: 10.1007/BF01200723. J Cancer Res Clin Oncol. 1993. PMID: 8270607 Free PMC article.
-
Ultrastructural pulmonary changes induced by intravenously administered 3-methylindole in goats.Am J Pathol. 1980 Jun;99(3):551-60. Am J Pathol. 1980. PMID: 7386595 Free PMC article.
-
Identification of amino acid determinants in CYP4B1 for optimal catalytic processing of 4-ipomeanol.Biochem J. 2015 Jan 1;465(1):103-14. doi: 10.1042/BJ20140813. Biochem J. 2015. PMID: 25247810 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
